Back to Search
DEBRA MARON, PHARMD
PHARMD
Pharmacist
NPI: 1871198754Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PS59428(FL)
Research & Publications (20)
Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
PMID 19576311·Am J Cardiol·2009
2-rct
Effect of PCI on quality of life in patients with stable coronary disease.
PMID 18703470·N Engl J Med·2008
4-observational
Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention.
PMID 18371554·J Am Coll Cardiol·2008
8-other
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
PMID 18268144·Circulation·2008
4-observational
Optimal medical therapy with or without PCI for stable coronary disease.
PMID 17387127·N Engl J Med·2007
4-observational
Does late PCI improve clinical outcome and survival in patients with arterial occlusion after MI?
PMID 17375052·Nat Clin Pract Cardiovasc Med·2007
8-other
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
PMID 17223420·Am J Cardiol·2007
4-observational
Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.
PMID 16945749·J Nucl Cardiol·2006
3-trial
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.
PMID 16781214·Am Heart J·2006
8-other
Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
PMID 16686806·J Gen Intern Med·2006
8-other
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
PMID 16098311·Am J Cardiol·2005
4-observational
Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.
PMID 14977858·Clin Cancer Res·2004
7-preclinical
Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
PMID 16265253·Nat Clin Pract Cardiovasc Med·2004
3-trial
Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.
PMID 14500361·Cancer Res·2003
8-other
Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial.
PMID 12824094·Arch Intern Med·2003
3-trial
Postexercise protein intake enhances whole-body and leg protein accretion in humans.
PMID 11984302·Med Sci Sports Exerc·2002
8-other
Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.
PMID 11435460·J Clin Invest·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9509 SAN JOSE BLVD
JACKSONVILLE, FL 32257 - Phone
- (904) 288-7865
Quick Facts
- NPI
- 1871198754
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile